From Molecule to Cure: The Discovery Journey
Development Phase
Once a promising compound for pharmaceutical development (API) has been identified, we conduct in vitro and in vivo experiments to gather information on:
- Absorption, distribution, and excretion in rodents
- Its potential benefits
- The optimal dosage
- The optimal route of administration (such as oral or injection)
- How it interacts with other actives
- Its effectiveness compared to similar actives
Preclinical phase
We also test your API to determine if it has the potential to cause side effects, also called toxicity. We collect several in vitro and in vivo data such as
- Cytotoxicity
- Post-mortem examination (necropsy)
- Histopathology and immunohistochemistry
- Immunological assays
- In vivo distribution and pharmacokinetics
- Maximum tolerated and ascending dose
- Etc.

Pharmacodynamics, pharmacokinetics, toxicology
Drug Discovery Experts
TransBIOTech offers the expertise required for drug discovery, including pharmacology, cellular and molecular biology, biochemistry, pharmacokinetics, and toxicology. Our scientists utilize cutting-edge methods to evaluate your potential compounds for efficacy and safety, prior to clinical development phases.
CONTACT US
Ultimately, your field of activity is ours. Contact us to discuss your project and see how TransBIOTech can accelerate it!



















